Medication info
Amifoprazine 10/160 mg

Amifoprazine 10/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
IQURE Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
28 tablets
Approval status
Active

MFDS item code 201602313 · Approved 2016.04.25

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
IQURE Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is inadequately controlled by monotherapy with amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used by patients who are allergic to its active ingredients or similar class medications, women who are pregnant or breastfeeding, and patients with severe renal or hepatic dysfunction. Patients with low sodium or fluid levels in the body may experience hypotension, so their status should be well assessed before taking the medication and should be closely monitored at the start of treatment. Patients with high potassium levels or those taking other medications that may increase potassium should frequently monitor their potassium levels. Patients with renal artery stenosis or those who have undergone kidney transplantation need cautious use and monitoring due to the risk of renal function deterioration. If symptoms of angioedema occur, the medication should be stopped immediately and should not be resumed. For patients with heart failure or after myocardial infarction, careful observation of renal function changes is necessary, and considerations for potential angina exacerbation should be made in acute myocardial infarction patients. Caution is required as dizziness or fatigue may occur when driving or operating machinery. This medication may interact with other antihypertensives, potassium supplements, diuretics, and specific anti-inflammatory agents, so other medications being taken must be disclosed to the doctor or pharmacist. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid taking it. It is not recommended for patients under 18 years of age, as safety and efficacy have not been sufficiently established. In case of overdose, symptoms such as hypotension, dizziness, and cardiac arrhythmias may occur, so it is essential to adhere to the prescribed dosage, and if any abnormal symptoms manifest, immediate medical attention should be sought. It is important to regularly check blood pressure, renal function, and electrolyte levels during the course of treatment to ensure no abnormalities are present.

Side effects

Pharyngitis, Influenza, Hypersensitivity, Visual impairment, Anxiety, Headache, Dizziness, Drowsiness, Positional dizziness, Sensory disturbances, Vertigo, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic hypotension, Hypotension, Cough, Throat and laryngeal pain, Diarrhea, Nausea, Abdominal pain, Constipation, Dry mouth, Rash, Erythema, Hyperhidrosis, Itching, Joint swelling, Low back pain, Arthritis, Muscle spasm, Lethargy, Frequency of urination, Polyuria, Erectile dysfunction, Edema, Neck edema, Facial edema, Peripheral edema, Fatigue, Flushing, Muscle weakness, Facial flushing, Decreased hemoglobin, Decreased hematocrit, Neutropenia, Thrombocytopenia, Hypersensitivity including serum sickness, Elevated serum potassium, Vasculitis, Elevated liver function tests, Angioedema, Myalgia, Renal failure, Kidney damage, Elevated serum creatinine, Insomnia, Decreased libido, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory infection, Viral infection, Diplopia, Thrombocytopenia, Leukopenia, Allergic reaction, Hyperglycemia, Insomnia, Mood changes, Tremor, Sensory decrease, Dysgeusia, Peripheral neuropathy, Hypertonicity, Arrhythmia, Bradycardia, Atrial fibrillation, Ventricular tachycardia, Myocardial infarction, Shortness of breath, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival hyperplasia, Hepatitis, Jaundice, Alopecia, Purpura, Skin depigmentation, Photosensitivity, Urticaria, Erythema multiforme, Stevens-Johnson syndrome, Myalgia, Urination disorders, Nocturia, Gynecomastia, Pain, Apathy, Chest pain, Weight loss, Weight gain, Elevated liver enzymes, Chest discomfort, Abdominal discomfort, Gastroesophageal reflux disease, Neck pain, Hypercholesterolemia, Hypoglycemia, Nervous irritability, Sensory decrease, Stevens-Johnson syndrome, Chest pain, Weight gain, Arthralgia, Skeletal pain, Rhabdomyolysis, Gingival hyperplasia, Gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly closed container. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius. Proper storage will help retain the medication's efficacy and safety over time.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

28 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.